Purified recombinant Human Myostatin Propeptide protein Expression System: E.coli Bioactivity: Determined by its ability to neutralize the Myostatin inhibitory effect of Mouse MPC-11 cells. The expected ED50 is 0.01-0.04 µg/mL in the presence of 50 ng/mL Myostatin.
Spezies: Human
Wirt: Escherichia coli (E. coli)
Recombinant
95,00%
SDS
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Buffer
Supplied as a lyophilized powder.
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at 4 °C until reconstitution. Following reconstitution aliquot and freeze at -20 °C for long term storage.
Target
Myostatin Propeptide
Hintergrund
Mature Myostatin is obtained by proteolytic processing of a biologically-inactive precursor protein, which contains an N-terminal propeptide of 243 amino acid residues. Myostatin Propeptide exhibits high binding affinity for myostatin and has been shown to be a potent inhibitor of Myostatin. Over-expression of myostatin propeptide in mice resulted in large increases (up to 200 %) in skeletal muscle mass, similar to those observed in Myostatin knockout mice.